…the swirling battle over psychedelics intellectual property
Carey Turnbull, a philanthropist who is a board member of several psychedelic non-profits including Usona Institute, created another non-profit, Freedom to Operate, to fight patents that infringe on existing knowledge. He believes Compass’s latest patent should not stand. “From FTO’s ongoing research, we understand that it is nearly impossible to crystallize psilocybin and not obtain this hydrate,” Turnbull wrote… “There are several examples of it in the prior art.”
…Compass Pathways’ fourth U.S. patent… The patent works to “expand their intellectual property kingdom,” said Mason Marks, senior fellow and project lead on the Project on Psychedelics Law and Regulation at Harvard Law School: “Like a landlord would want to expand and buy more properties, they’re trying to lock up as much IP as they can to solidify their position in the market.” “I have no doubts the reasons behind this are to protect a competitive position around psilocybin,” said Graham Pechenik, patent attorney and founder of Calyx Law. The latest patent decision is likely to be challenged…
Original Article (Stat News):
Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property
Artwork Fair Use: Almonroth
